Teva Shares Up on Mylan-Pfizer Merger - Hamodia.com
Pfizer Wins Lyrica Patent Infringement Case Against Teva and Other Generic Drug Manufacturers | American University Intellectual Property Brief
Investors question green tint of Teva's $5bn sustainability bond | Financial Times
Manufacturing alerts and issues at Teva, Pfizer, and more
Generic Viagra Half the Price Teva Pfizer
Pfizer, Teva running short on antibiotic azithromycin amid COVID-19 therapy hunt | FiercePharma
Teva Pharmaceuticals - Wikipedia
Better Big Pharma Dividend Stock: Pfizer Or Teva? | Seeking Alpha
Teva says it's in talks with COVID vaccine makers to help produce shots | The Times of Israel
Bad news for Momenta and Pfizer is a blessing for Teva
Pfizer to settle Xeljanz suit with Teva
Pfizer, Takeda Reach $2.15 Billion Settlement With Teva, Sun Pharma - WSJ
Innovation lab driven by AI formed by AstraZeneca, Merck, Pfizer and Teva
Drug giants line up for Irish legal battle over patents - Independent.ie
Pfizer, GSK and Teva lead 2022's round of January drug price hikes: GoodRx | FiercePharma
Pfizer's Kindler KO'd by Teva's Yanai
FDA panel votes against Pfizer's tanezumab for osteoarthritis pain
Pfizer, Teva and Actavis Vie to Buy Ratiopharm - The New York Times
Teva, Mylan: Desperate Times Call For Desperate Measures (NYSE:TEVA) | Seeking Alpha
Pfizer links with Synthon on generic Copaxone - PMLiVE
Pfizer Looks to Fill Void for Chemo Drug After Teva Discontinues Its Generic Version | BioSpace
Recon: FDA clears Pfizer booster for 12- to 15-year-olds; Teva found liable in New York opioid trial | RAPS
